Isradipine

From Wikipedia, the free encyclopedia

Isradipine
Systematic (IUPAC) name
methyl propan-2-yl 2,6-dimethyl-4- (8-oxa-7,9-diazabicyclo[4.3.0] nona- 2,4,6,9- tetraen- 5-yl)- 1,4-dihydropyridine- 3,5-dicarboxylate
Identifiers
CAS number 75695-93-1
ATC code C08CA03
PubChem 3784
DrugBank APRD00298
Chemical data
Formula C19H21N3O5 
Mol. mass 371.387 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 95%
Metabolism  ?
Half life 8 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Isradipine is a calcium channel blocker of the dihydropyridine class.

[edit] Further reading

    • Hattori T, Wang P (2006). "Calcium antagonist isradipine-induced calcium influx through nonselective cation channels in human gingival fibroblasts.". Eur J Med Res 11 (3): 93-6. PMID 16751108. 
    • Ganz M, Mokabberi R, Sica D (2005). "Comparison of blood pressure control with amlodipine and controlled-release isradipine: an open-label, drug substitution study.". J Clin Hypertens (Greenwich) 7 (4 Suppl 1): 27-31. PMID 15858400. 
    • Johnson B, Roache J, Ait-Daoud N, Wallace C, Wells L, Dawes M, Wang Y (2005). "Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects.". Int J Neuropsychopharmacol 8 (2): 203-13. PMID 15850499. 
    • Fletcher H, Roberts G, Mullings A, Forrester T (1999). "An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia.". J Obstet Gynaecol 19 (3): 235-8. PMID 15512286. 

    [edit] External links


    In other languages